| Document Date: 2012-12-12 15:40:28
Open Document File Size: 75,69 KBShare Result on Facebook
City Philadelphia / New York / / Company Oxford University Press / / Facility Jefferson Headache Center / Thomas Jefferson University / / IndustryTerm treatment of migraine / migraine treatment / / MedicalCondition peripheral vascular disease / headache / non-opioid-responsive syndrome / acute migraine / uncontrolled hypertension / psychiatric illness / nausea / acute dystonia / migraine / cerebrovascular disease / cardiovascular disease / diabetes / Drugs (NSAIDs) Sterile inflammation / metabolic syndrome / Wolff’s Headache / pain / renal insufficiency / coronary artery disease / hypersensitivity / restlessness / Opioids Migraine / longer-lasting headaches / MS / migraine headache / tardive dyskinesia / lightheadedness / oral gabapentin abort migraine / akathisia / / Organization Jefferson Headache Center / FDA / Oxford University / MS Ed Department of Neurology / Thomas Jefferson University / / Person David W. Dodick / Stephen D. Silberstein / Stephanie J. Nahas / Richard B. Lipton / / Product methylprednisolone / olanzapine / haloperidol / dexamethasone / ibuprofen / gabapentin / valproic acid / droperidol / Lidocaine / magnesium sulfate / diclofenac potassium / prednisone / prochlorperazine / fentanyl / naproxen / Piroxicam / metoclopramide / / ProvinceOrState New York / /
SocialTag |
Symptomatic Treatment Options when Triptans and Ergots are Contraindicated Stephanie J. Nahas, MD, MS Ed Department of Neurology, Thomas Jefferson University and Jefferson Headache Center, Philadelphia, PA